Effect of linagliptin vs. placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: The CARMELINA Randomized Clinical Trial - Rosenstock, J; Perkovic, V; Johansen, O E (JAMA, 2019)
CARMELINA Investigators et al.